glp-1 for prediabetes Glucagon-like peptide-1 Metabolic disorders in prediabetes: From

The LEADER Publication Committee on behalf of the LEADER Trial Investigators, Zinman B, Nauck MA, Bosch-Traberg H, Frimer-Larsen H, rsted DD, et al

The Shot Day Protocol: Preventing Nausea Before It Starts Many people find that their nausea follows a predictable clock, kicking in anywhere from 8 to 72 hours after taking their dose

These medications are not recommended for patients with certain types of thyroid cancers, pancreatitis, gallbladder disease, hypoglycemia, decreased kidney function, or who are pregnant

While PD1 antagonist drugs currently reign as the top-selling drug class, this status quo is poised for a shift

Individualized care enables providers to adjust doses, recommend dietary changes, and address any complications as they arise